CH565159A5 - - Google Patents

Info

Publication number
CH565159A5
CH565159A5 CH554472A CH554472A CH565159A5 CH 565159 A5 CH565159 A5 CH 565159A5 CH 554472 A CH554472 A CH 554472A CH 554472 A CH554472 A CH 554472A CH 565159 A5 CH565159 A5 CH 565159A5
Authority
CH
Switzerland
Application number
CH554472A
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of CH565159A5 publication Critical patent/CH565159A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01LSEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L2224/00Indexing scheme for arrangements for connecting or disconnecting semiconductor or solid-state bodies and methods related thereto as covered by H01L24/00
    • H01L2224/01Means for bonding being attached to, or being formed on, the surface to be connected, e.g. chip-to-package, die-attach, "first-level" interconnects; Manufacturing methods related thereto
    • H01L2224/26Layer connectors, e.g. plate connectors, solder or adhesive layers; Manufacturing methods related thereto
    • H01L2224/2612Auxiliary members for layer connectors, e.g. spacers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
CH554472A 1971-04-16 1972-04-14 CH565159A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB964071A GB1401612A (en) 1971-04-16 1971-04-16 2,4-diamino-5-benzylpyrimidines and preparations thereof

Publications (1)

Publication Number Publication Date
CH565159A5 true CH565159A5 (xx) 1975-08-15

Family

ID=9875907

Family Applications (1)

Application Number Title Priority Date Filing Date
CH554472A CH565159A5 (xx) 1971-04-16 1972-04-14

Country Status (25)

Country Link
US (1) US3822264A (xx)
JP (1) JPS5324433B1 (xx)
AR (1) AR193078A1 (xx)
AT (1) AT316560B (xx)
AU (1) AU468410B2 (xx)
BE (1) BE782154R (xx)
CA (1) CA978954A (xx)
CH (1) CH565159A5 (xx)
CS (2) CS178105B2 (xx)
DD (1) DD97653A6 (xx)
DE (2) DE2218221C3 (xx)
DK (1) DK132221C (xx)
ES (1) ES401796A2 (xx)
FI (1) FI57400C (xx)
FR (1) FR2133753B2 (xx)
GB (1) GB1401612A (xx)
HU (1) HU165865B (xx)
IE (1) IE36289B1 (xx)
IL (1) IL39221A (xx)
NL (1) NL163214C (xx)
NO (1) NO136046C (xx)
PL (1) PL75399B3 (xx)
SE (2) SE405118B (xx)
ZA (1) ZA722533B (xx)
ZM (1) ZM7072A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515948A (en) * 1973-09-12 1985-05-07 Hoffmann-La Roche Inc. 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines
US4039543A (en) * 1974-12-24 1977-08-02 Hoffmann-La Roche Inc. Benzylpyrimidines
DE2720771C3 (de) * 1977-05-09 1979-11-29 Ludwig Heumann & Co Gmbh, 8500 Nuernberg 2,4-Diamino-5-(33-dimethoxy-4thioalkyl-benzyD-pyrimidine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3250132C2 (de) * 1981-11-09 1997-01-16 Mallinckrodt Veterinary Inc Verfahren zur Herstellung von 2,4-Diamino-5-benzyl-pyrimidinen und neue Zwischenprodukte des Verfahrens
FR2516081B1 (fr) * 1981-11-09 1987-05-29 Wellcome Found Synthese de benzylpyrimidines et produits intermediaires pour cette synthese

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1720031A1 (de) * 1966-02-19 1972-08-03 Wellcome Found Biologisch wirksame 5-Benzylpyrimidin-Derivate und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
NO136046C (no) 1977-07-13
SE405118B (sv) 1978-11-20
AU468410B2 (en) 1973-10-18
JPS5324433B1 (xx) 1978-07-20
FR2133753A2 (xx) 1972-12-01
NL7205046A (xx) 1972-10-18
AU4117772A (en) 1973-10-18
SE417097B (sv) 1981-02-23
IE36289L (en) 1972-10-16
FI57400B (fi) 1980-04-30
IL39221A (en) 1975-11-25
DE2265413B1 (de) 1980-04-10
NO136046B (xx) 1977-04-04
IE36289B1 (en) 1976-09-29
IL39221A0 (en) 1972-06-28
CS178140B2 (xx) 1977-08-31
DE2218221C3 (de) 1979-02-01
DD97653A6 (xx) 1973-05-14
NL163214C (nl) 1980-08-15
SE7503993L (xx) 1975-04-08
DE2265413C2 (de) 1980-12-04
FI57400C (fi) 1980-08-11
BE782154R (fr) 1972-10-16
HU165865B (xx) 1974-11-28
CA978954A (en) 1975-12-02
AR193078A1 (es) 1973-03-30
ZM7072A1 (en) 1974-03-21
US3822264A (en) 1974-07-02
DK132221B (da) 1975-11-10
ES401796A2 (es) 1975-03-01
FR2133753B2 (xx) 1975-10-10
ZA722533B (en) 1973-11-28
CS178105B2 (xx) 1977-08-31
DE2218221A1 (de) 1972-11-02
GB1401612A (en) 1975-07-16
AT316560B (de) 1974-07-25
DK132221C (da) 1976-04-20
DE2218221B2 (de) 1978-05-24
NL163214B (nl) 1980-03-17
PL75399B3 (en) 1974-12-31

Similar Documents

Publication Publication Date Title
CS178409B2 (xx)
ATA136472A (xx)
AR196074A1 (xx)
CS178105B2 (xx)
AU2952271A (xx)
AU2564071A (xx)
AU3005371A (xx)
AU2485671A (xx)
AU2941471A (xx)
AR202997Q (xx)
AR199640Q (xx)
AU2456871A (xx)
AU2473671A (xx)
AU2415871A (xx)
AU2399971A (xx)
AU2486471A (xx)
AU2963771A (xx)
AU2577671A (xx)
AU2455871A (xx)
AR192311Q (xx)
AU2503871A (xx)
AU2885171A (xx)
AU2875571A (xx)
AU3025871A (xx)
AU1109576A (xx)

Legal Events

Date Code Title Description
PL Patent ceased